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Regulation of renal proximal tubule Na-K-ATPase by prostaglandins
Abstract
Prostaglandins (PGs) play a number of roles in the kidney, including regulation of salt and water
reabsorption. In this report, evidence was obtained for stimulatory effects of PGs on Na-K-ATPase in
primary cultures of rabbit renal proximal tubule (RPT) cells. The results of our real-time PCR studies
indicate that in primary RPTs the effects of PGE2, the major renal PG, are mediated by four classes of
PGE (EP) receptors. The role of these EP receptors in the regulation of Na-K-ATPase was examined at the
transcriptional level. Na-K-ATPase consists of a catalytic α-subunit encoded by the ATP1A1 gene, as well
as a β-subunit encoded by the ATP1B1 gene. Transient transfection studies conducted with pHβ1-1141
Luc, a human ATP1B1 promoter/luciferase construct, indicate that both PGE1 and PGE2 are stimulatory.
The evidence for the involvement of both the cAMP and Ca2+ signaling pathways includes the inhibitory
effects of the myristolylated PKA inhibitor PKI, the adenylate cyclase (AC) inhibitor SQ22536, and the PKC
inhibitors Gö 6976 and Ro-32-0432 on the PGE1 stimulation. Other effectors that similarly act through
cAMP and PKC were also stimulatory to transcription, including norepinephrine and dopamine. In addition
to its effects on transcription, a chronic incubation with PGE1 was observed to result in an increase in NaK-ATPase mRNA levels as well as an increase in Na-K-ATPase activity. An acute stimulatory effect of
PGE1 on Na-K-ATPase was observed and was associated with an increase in the level of Na-K-ATPase in
the basolateral membrane.
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Abstract
Prostaglandins (PGs) play a number of roles in the kidney, including regulation of salt
and water reabsorption. In this report evidence was obtained for stimulatory effects of
PGs on Na,K-ATPase in primary cultures of rabbit renal proximal tubule (RPT) cells.
The results of our RealTime PCR studies indicate that in primary RPTs the effects of
PGE2, the major renal PG, are mediated by 4 classes of PGE (EP) receptors. The role of
these EP receptors in the regulation of Na,K-ATPase was examined at the transcriptional
level. Na,K-ATPase consists of a catalytic α subunit encoded by the ATP1A1 gene, as
well as a β subunit encoded by the ATP1B1 gene. Transient transfection studies
conducted with pHß1-1141 Luc, a human ATP1B1 promoter/luciferase construct,
indicate that both PGE1 and PGE2 are stimulatory. The evidence for the involvement of
both the cAMP and Ca2+ signaling pathways includes the inhibitory effects of the
myristolylated protein kinase A (PKA) inhibitor PKI, the adenylate cyclase (AC)
inhibitor SQ22536, and the Protein Kinase C (PKC) inhibitors Gö 6976 and Ro-32-0432
on the PGE1 stimulation. Other effectors that similarly act through cAMP and PKC were
also stimulatory to transcription, including norepinephrine and dopamine. In addition to
its effects on transcription, a chronic incubation with PGE1 was observed to result in an
increase in Na,K-ATPase mRNA levels as well as an increase in Na,K-ATPase activity.
An acute stimulatory effect of PGE1 on Na,K-ATPase was observed, and was associated
with an increase in the level of Na,K-ATPase in the basolateral membrane.
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Introduction

Prostaglandins (PGs) are involved in mediating the response of the kidney to changes
in Na+ balance, by regulating renal ion transport, glomerular filtration, renin release, and
blood flow (9, 32, 61). The ultimate effect of PGs is on blood pressure (45). The specific
effects of PGs on the nephron have been difficult to define by means of renal clearance
studies, because PGs are potent vasodialators (61). Thus, many of the previous studies
with PGs were conducted with isolated perfused tubules (9). These studies have been
concerned with the acute effects of PGs (9).

The results of the studies with isolated perfused tubules have clearly indicated that PGs
do indeed affect transport in different nephron segments, although each nephron segment
responds to PGs in a distinctive manner (9). For example, a15 min incubation with PGE2
inhibited Na+ transport across the rabbit cortical collecting tubule (CCT) while having no
effect on the rabbit medullary thick ascending limb (15), (35). A consequence of the
inhibition of Na+ transport in the CCT was natriuresis. The acute inhibition of Na+
reabsorption in the CCT is associated with a reduction in Na, K-ATPase activity (57),
unlike the acute stimulatory effect of PGs on distal tubule Na,K-ATPase (57). In contrast
to the extensive studies of acute PG effects, chronic PGs effects have not been conducted
with isolated nephron segments, due to their limited viability.

For this reason, we have studied long-term effects of PGs on growth and transport
using kidney epithelial cell culture systems. When studying the MDCK cell line, we
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observed that both PGE1 and 8Br-cAMP increased the activity of the Na,K-ATPase (67).
The Na,K-ATPase consists of both an α subunit (with catalytic activity) and a β subunit,
involved in insertion of Na,K-ATPase in the basolateral membrane. The level of both the
α and the β subunits increased in PGE1 and 8BrcAMP treated MDCK cells. In addition,
the level of the mRNAs for the α1 and the ß1 subunit also increased (65). However, the
level of ß1 subunit mRNA increased to a larger extent than α1 subunit mRNA, Thus in
our initial studies, the regulation of transcription of the ß1 subunit gene (ATP1B1) was
examined in detail, and the signal transduction pathways involved in β subunit gene
transcription were defined (65). Evidence was obtained for the involvement of Protein
Kinase A and Protein Kinase C.

However, it was unclear whether the signal transduction pathways involved in the
regulation of ATP1B1 transcription are unique to MDCK cells, which serve as a distal
tubule model, or whether tubule epithelial cells in other nephron segments are subject to
similar types of control. The renal proximal tubule (RPT) is of particular interest in
these regards because this nephron segment is involved in the response of the kidney to
changes in Na+ status (3). A number of hormones and other effectors mediate the
response of the kidney to such changes, including PGs (21).

To study PG effects on the RPT, we have employed a primary rabbit RPT cell culture
system, which closely resembles normal RPTs in the animal (62, 63). The primary RPT
cells possess a polarized morphology, as well as transport systems which are involved in
polarized solute transport, including an apical Na+/glucose cotransport system (SGLT1)
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(14, 54), a basolateral p-Aminohippurate (PAH) transport system (OAT1) (72) (14, 30,
36), and a Na+/Phosphate cotransport system (Npt2) (70) . In addition, the cultures
respond to Parathyroid Hormone (PTH) (14), insulin (69), dopamine (31), and
Angiotensin II (Ang II) (29) in a manner that is characteristic of RPT cells. Ang II
stimulates the synthesis of PGs (1) including PGE2, PGF2 , and 6-keto-PGF 1 (1).
α

α

In this report effects of PGs on Na, K-ATPase in the primary RPT cell cultures are
examined. In order to determine whether the observed increase in the Na,K-ATPase ß1
subunit following treatment with PGE1 can be explained by transcriptional regulation,
transient transfection studies were conducted with pHß1-1141 Luc, a human Na,KATPase ß1 promoter/Luciferase construct (22). The involvement of both Protein Kinase
A (PKA) and Protein Kinase C (PKC) in signaling has been examined. In addition, the
effects of Arachidonic Acid (AA) and its metabolites, norepinephrine and dopamine have
been studied because these effectors, like PGs, are produced in response to changes in
Na+ balance. In order to evaluate the physiologic significance, both the acute and chronic
affects of PGs on Na,K-ATPase activity have been examined.
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Materials and Methods
Materials
Hormones, human transferrin, PGs, and other chemicals were from Sigma Aldrich
Chemical Corp (St. Louis, Mo.). PKC inhibitors were from Calbiochem (La Jolla,
Calif.). PG receptor agonists and antagonists were from Cayman Chemical (Ann Arbor,
Mich.). Dulbecco’s Modified Eagle’s Medium (DME), Ham’s F12 Medium (F12),
soybean trypsin inhibitor, and lipofectamine were from Invitrogen Corp. (Carlsbad,
Calif.). Class IV collagenase was from Worthington (Freehold, NJ). Mouse monoclonal
antibodies against the Na,K-ATPase α1 (sc-21712), ß1 subunit (sc-21713) and goat antimouse horse radish peroxidase conjugate were from Santa Cruz Biotech (Santa Cruz,
Calif.). Immun-Star HRP Substrate, nitrocellulose, acrylamide, and other electrophoresis
reagents were from Bio-Rad Corp. (Hercules, Calif.). Streptavidin sepharose beads were
from Amhersham Corp. The Galacto-Star System was obtained from Applied
Biosystems (Bedford, Mass.). Both the p-SV ß-galactosidase (pSVßgal) plasmid, and
Reporter Lysis Buffer were from Promega Corp. (Madison, Wisc). The Prism 5 program
was obtained from Graph Pad Software, Inc. (San Diego, Calif.).

86

Rb+ (>1 µCi/µg) was

obtained from Perkin Elmer Corp. , Billerica, Ma). Transwells were obtained from
Corning, Inc. (Corning, NY).

Primary RPT Cultures
The basal medium for primary RPT cells consists of a 1:1 mixture of Dulbecco’s
Modified Eagle’s Medium (DME) and Ham’s F12 medium (F12) (pH 7.4) containing 15
mM HEPES, 20 mM Na+ bicarbonate, penicillin (92 units/ml) and kanamycin (0.01%)
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(DME/F12) (14). Immediately prior to use, the medium was further supplemented with
bovine insulin (5 µg/ml), human transferrin (5 µg/ml), 50 nM hydrocortisone (Medium
RK1), and, if appropriate, other factors(14). Water used for medium and growth factor
preparations was purified using a Milli-Q deionization system. Iron oxide in 0.9% NaCl
was prepared, sterilized in an autoclave, and diluted with PBS prior to use (18).

To initiate primary rabbit kidney proximal tubule (RPT) cell cultures (14, 36), a
kidney from a male, New Zealand White rabbit (2-2.5 kg) was perfused via the renal
artery, first with Phosphate Buffered Saline (PBS), and subsequently with sterile 0.5%
(w/v) iron oxide. The renal cortex was sliced, homogenized with a sterile Dounce
homogenizer (loose pestle), and the homogenate (consisting of nephron segments) was
sequentially passed through a 253 µ and an 83 µ mesh. The renal proximal tubules and
the glomeruli on the 83 µ mesh were transferred into a 50 ml conical tube containing
DME/F12, and a sterile stir bar. The glomeruli (with bound iron oxide) were removed
with the stir bar, resulting in a preparation of tubules that stained positively for γglutamyltranspeptidase (γGT) (Taub, unpublished), a distinctive RPT marker.

Tubules to be utilized for primary cultures were treated with 0.05 mg/ml collagenase in
DME/F12 containing .5 µg/ml soybean trypsin inhibitor for 2 min at 23o C. The tubules
were washed twice by centrifugation, resuspended in DME/F12, and plated in 35 mm
dishes containing Medium RK-1. The medium was changed the day after plating and
every 2 days thereafter.
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Transient Transfection Studies
Primary cultures were cotransfected with pHß1-1141 Luc, a human ß1 subunit
promoter/luciferase construct (1 µg), and the pSVßgal plasmid (0.2 µg), to correct for
transfection efficiency. Transfections were carried out utilizing lipofectamine in
antibiotic free DME/F12 supplemented with 5 µg/ml insulin and 5 µg/ml transferrin. The
next day, the medium was changed to antibiotic containing DME/F12 supplemented with
5 µg/ml insulin and 5 µg/ml transferrin. , The cultures were incubated for 2 hrs in a
humidified 5% CO2/95% air humidified environment, and then treated with appropriate
effectors for 4 hrs (unless otherwise indicated). Four cultures were used per condition to
maintain accuracy of determinations of +/- 10-20%. At the end of the incubation, the
monolayers were solubilized in Reporter Lysis Buffer, and spun for 1 minute at 13,600 x
g in a microcentrifuge. The cell lysates were then assayed for luciferase and β
galactosidase (β gal) activity.

To measure luciferase activity, an aliquot of the cell lysate was placed in 0.1 ml a
buffer containing 20 mM Tricine, 1.07 mM (MgCO3) . 4Mg(OH)2, 2.67 mM MgSO4, 0.1
mM EDTA, 33.3 mM dithiothreitol, 270 µM Coenzyme A, 470 µM luciferin and 530 µM
ATP. The light units emitted were determined using a Packard Tricarb 4530 scintillation
counter with the coincidence circuit turned off. As a control in these studies, luciferase
activity was determined as a function of light emitted per unit of luciferase activity, using
purified firefly luciferase (Sigma/Aldrich Corp). Luciferase determinations were made
within light units in which activity was linear as a function of increasing luciferase
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activity (which was obtained with activity measurements giving no more than 3.1 x 106
cpm). Luciferase determinations were made with 3-6 day old cultures.

To determine ß-gal activity, aliquots of cell lysates were incubated in a reaction buffer
containing the Galacton-Star® substrate (a component of the Galacto-StarTM System).
The light emitted was measured as described above. ß-gal activity was expressed as a
fraction of the activity in Control transfected cultures. As a control ß-gal activity was
determined as a function of increasing levels of purified ß-gal activity. ß-Gal
determinations were after a 90-120 min incubation, during which time the activity was
constant. ß-Gal determinations conducted within a range, in which the activity was
constant as a function of increasing ß-gal activity (for activity levels giving
measurements of up to 2 x 106 cpm).

Each luciferase determination was normalized with respect to ß-gal activity. For each
condition a luciferase value was obtained by calculating the average of quadruplicate
determinations (+/- the Standard Error of the Mean (SEM)). This average value was
compared to the Control value (obtained with cultures maintained with insulin and
transferrin alone). Both a One Way analysis of variance (ANOVA), and the NewmanKeuls Multiple Comparison Test (using Prism 5 software) were employed to determine
the statistical significance of the results. Differences were determined to be significant
when p< 0.05. The effects of regulatory molecules on luciferase and ß-gal activity were
determined in at least 2 independent culture sets.
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RealTime PCR
Primary RPT cell cultures were treated with appropriate effector molecules. RNA was
purified from the cultures using an RNA -4PCR kit (Ambion). Genomic DNA was first
removed using TURBO DNAase I (Ambion), and then cDNA was synthesized from the
purified RNA using reverse transcriptase. Transcripts were amplified in a BioRad I
Cycler using iQ Sybr Green Supermix, as well as 5 µM forward and reverse primers
complementary to appropriate template on the cDNA. After amplification Ct values were
calculated using the Bio-Rad IQ5 program. The relative mRNA levels were quantitated
from using the Pfaffl method (50). GAPDH mRNA was used as an internal control in the
calculations of relative mRNA levels.

The primers were designed by using the Primer-BLAST Primer designing tool on the
NCBI website, and synthesized by Invitrogen. Included amongst the cDNAs used for
primer design are rabbit EP1 (Accession Number AF043491.1, PTGER1),
AGAGGCCCAATCGGTTAAGT, AGCTTCATTTACCCTCGCAA; rabbit EP2
(Assession Number NM_001082659, PTGER2), CTGCAGCATCTGGAAGATCA,
CATGGGCTCCTTGAGGATAA; rabbit EP3 (Assession Number NM_001122935.1,
PTGER3), TAATAGCTGTTCGCCTGGCT, GACGTTCCTGTTCTCACGCT; rabbit
EP4 (Assession Number NM_001082259.1, PTGER4),
CACCTACATGAAGGGCCAGT, GGCTGTAGAAGTAGGCGTGG; rabbit ATP1A1
(Assession Number AF235024, ATP1A1_RABIT), TGACTCTCCTGCTCTGAAG,
CACAATGGAAGCGAAGTTATC; rabbit ATP1B1 (Assession Number AF204927,
ATP1B1_RABIT), ACTGGCAAGCGAGATGAAG, ATGGTGAGGTTGGTGAACTG;
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and rabbit GAPDH (Assession Number L23961, RABGLY3PHO),
GCCCTCAATGACCACTTTGT, TCATGACAAGGTAGGGCTCC.

Preparation of Cell Lysates from Cultures on Polystyrene
To determine the effect of exogenous PG and other effectors on Na,K-ATPase levels,
primary RPT monolayers were grown in Medium RK-1 containing 10-6 M indomethacin,
to inhibit endogenous PG biosynthesis. The cultures were treated on a daily basis for 4
days with effector molecules, also in the presence of indomethacin. Cell lysates were
prepared by first washing the RPTs twice with ice-cold PBS at 4o C, and then solubilizing
the monolayers in lysis buffer (20 mM Tris, pH 7.5, 1% Triton X-100, 120 mM NaCl, 1
mM EDTA, 1 mM phenylmethylsulfonyl fluoride (PMFS), 1 µg/ml aprotinin, 1 µg/ml
leupeptin, 1 µg/ml pepstatin, 1 mM Na+ orthovanadate and 1 mM NaF). The cell lysates
were transferred from the culture dishes into microfuge tubes, using a rubber policeman.

Cell Surface Biotinylation Studies
Rabbit kidney proximal tubules were plated on Transwell inserts (24 mm, 0.4 µm
polycarbonate membranes, Corning #3412) in Medium RK1 at twice the density used for
cultures on polystyrene. The medium was changed initially after days 3 and 7 in culture,
and daily, thereafter. Cell surface biotinylation studies were conducted after 10-12 days.

To conduct cell surface biotinylation studies, the medium was changed in transwell
cultures. Two hrs later, the monolayers were incubated for 30 minutes in the presence or
absence of effector molecule (PG). The monolayers were then placed on ice, washed,
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first with ice-cold DME/F12 and then twice with PBS supplemented with 0.1 mM CaCl2
and 1.0 mM MgCl2 (PBS-CaMg). The cultures were subsequently incubated at 4o C for
20 min. with NHS-ss-biotin (0.5 mg/ml) in biotinylation buffer (10 mM triethanolamine,
pH 9.0, 2 mM CaCl2 and 150 mM NaCl), with gentle horizontal motion. This was
followed by a second 20 min incubation in biotinylation buffer, 2 washes with ice-cold
PBS-Ca-Mg containing 100 mM glycine, and a final 20 min incubation at 4o C in PBSCa-Mg containing 100 mM glycine. The monolayers were then quickly washed with
PBS-Ca-Mg. The filters were transferred to 35 mm dishes and the monolayers solubilized
in 1 ml of lysis buffer (1% Triton X-100, 150 mM NaCl, 5 mM EDTA, 50 mM Tris, pH
7.5, for 1 hr at 4 o C. Cell lysates were removed from the filters with rubber policeman,
and centrifuged at 14, 000 x g for 10 min at 4 o C.

Aliquots of the cell lysates (100-250 µg of protein) were used for the purification of
biotinylated cell surface proteins, and protein determinations (Bradford method). Cell
lysates were incubated overnight with streptavidin sepharose beads. , The beads were
washed 3 times with lysis buffer, twice with a high salt wash buffer ((lysis buffer
containing 0.1% Triton X-100\ and 500 mM NaCl), and once with 10 mM Tris, pH 7.5.
Proteins were eluted by heating 5 min at 100o C in SDS-PAGE sample buffer.

Western Analysis
Na,K-ATPase in cell lysates was subjected to a Western analysis. Samples of the
streptavidin precipitates, and whole cell lysates (equalized with regards to protein by the
Bradford method) were separated by electrophoresis through 7.5% SDS/polyacrylamide
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gels, along with parallel samples of purified dog Na,K-ATPase and molecular weight
markers. The proteins in the gel were transferred to nitrocellulose using a Trans-Blot
Apparatus (Bio-Rad). Nitrocellulose blots were blocked for 1 hr in Tris-buffered saline
(TBS) containing 0.1% (v/v) Tween 20 (TTBS), followed by a 2 hr incubation in TTBS
containing primary antibody (either an anti-Na,K-ATPase α or β subunit monoclonal
antibody). The blots were washed (5x with TTBS, 5 min/wash), and then incubated 45
min with a secondary antibody (goat anti-mouse horse radish peroxidase conjugate)
After washing (6 x with TTBS, 15 min/wash). Bands were visualized following a 5 min
incubation in Immun-Star HRP Luminol/Enhancer by exposure to Bio Max MS2 Film.
Na,K-ATPase α and β subunits were identified by their comigration with purified dog
Na,K-ATPase and molecular weight.

As controls for equal loading, blots of biotinylated proteins were subsequently
incubated 1 hr with mouse anti-biotin-alkaline phosphatase conjugate. Bands were
visualized by incubation in a reaction mixture containing 0.33 mg/ml nitroblue
tetrazolium (NBT) and 0.17 mg/ml 5-bromo-4-chloro-3-indolyl phosphate (BCIP) in 0.1
M NaCl and 0.05 N MgCl2. The X-Ray films and blots were scanned with a Bio-Rad
Scanning Densitometer, and the relative intensity of bands was quantitated using the
Quantity One Program.

Na,K-ATPase Assays in Vesicle Preparations
The Na,K-ATPase activity in cell lysates was measured by the method of Forbush (25) as
previously described by Taub et al. (67). To summarize, primary RPT monolayers in 100
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mm dishes were washed twice with sonication buffer (140 mM NaCl, 10 mM KCl, 10
mM HEPES, pH7.4) and removed with a rubber policeman. The cells were disrupted by
sonication at 4 o C using three 5 second blasts. The sonicated material was diluted five
fold into preincubation buffer (10 mg/ml BSA, 2 mM EDTA, 25 mM HEPES, pH 7.0 and
0.6 mg/ml SDS), and incubated 10 minutes at 23 o C. The samples were then diluted
fivefold using 3 mg/ml BSA in 25 mM HEPES, pH 7.0 (to reduce the SDS
concentration), and maintained at 4 o C. Aliquots of this diluted material were added to
assay mixture containing 120 mM NaCl, 25 mM KCl, 4 mM Na2ATP, 4 mM MgCl2, 1
mM EDTA and 60 mM Tris-HCl, pH 7.5, and incubated 10 min at 37 o C.
Determinations were in triplicate, both in the absence and in the presence of 1 mM
ouabain. The inorganic phosphate released from ATP was assayed using a modification
of the Baginski method (5) (25). In each cell culture condition, the specific Na,KATPase activity was determined by calculating the difference in inorganic phosphate
released in the presence and absence of 1 mM ouabain. Determinations were
standardized with respect to protein content by the Bradford method (10).

86

Rb+ Uptake Studies
To study chronic effects of PGE1, Rubidium (Rb+) uptake studies were conducted with

confluent monolayers of primary RPT cells on 35 mm dishes, as previously described for
MDCK cells (67). To summarize, primary RPT cells were grown to confluence in
Medium RKT. The cultures were then maintained in experimental medium (DME/F12
supplemented with 5 µg/ml insulin 5 µg/ml transferrin, and other appropriate
supplements). The medium was changed on a daily basis. On the day of the uptake
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experiment, the medium was once again changed, preincubating cells in either the
presence or absence of 1 mM ouabain for 4 hours at 37o C in a 5% CO2/95% air
humidified environment. Immediately prior to the uptake period, the monolayers were
washed twice at 23 o C with 2 ml of uptake buffer (10 mM Tris, pH 7.4, and 140 mM
NaCl). The monolayers were then incubated for 5 minutes at 23o C in uptake buffer
containing 1 mM RbCl, and 6 µCi/ml 86Rb+. Ouabain (1 mM) was also present in the
uptake buffer of cultures that had been preincubated with ouabain. At the end of the
uptake period, the cultures were rapidly washed three times with ice-cold wash buffer (10
mM Tris, pH 7.4, and 100 mM MgCl2), and lysed in 0.2 N NaOH. The cell lysates were
neutralized with HCl. One half of the cell lysate was used for scintillation counting and
the remainder was used for protein determinations, following the Bradford Method (10).
The labeled Rb+ uptake was determined in each of the cultures using a scintillation
counter. The quantity of Rb+ uptake in nmoles was determined from the determination of
the specific activity of the labeled uptake buffer. Each Rb+ uptake determination was
standardized with regards to protein. All uptake determinations were in triplicate and
corrected for zero time uptake. Values are averages +/- SEM.

To study acute affects of PGE1 on Na,K-ATPase activity, ouabain-sensitive 86Rb+ uptake
was determined by a modification of the method of Feraille et al. (20) . To summarize,
monolayers of primary RPTs were washed twice with K+ free DME/F12 buffered with
20 mM HEPES, pH 7.4, but lacking bicarbonate. The cells were then preincubated for 30
minutes at 23o C in the same medium supplemented with 5 µg/ml insulin, 5 µg/ml
transferring and 1 µM indomethacin, in either the presence or absence of 1 mM ouabain.
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Subsequently, agonists were added, followed by a second 30 min incubation period.
86

RbCl was then added to each culture ( 6 µCi/dish). After a 15 minute incubation, the

uptake was stopped by cooling on ice, removal of the culture medium, and 3 washes with
ice-cold wash buffer (150 mM choline chloride, 1.2 mM MgSO4, 1.2 mM CaCl2, 2 mM
BaCl2 and 5 mM HEPES, pH 7.4). The cultures were lysed in 1% (wt/vol) Na+
deoxycholate. Radioactivity in the lysate was measured in a scintillation counter, and
protein by the Bradford method, as described above. All uptake determinations were
conducted in triplicate, and corrected for zero time uptake. To determine the ouabainsensitive component of Rb+ uptake in each condition, ouabain-insensitive Rb+ uptake was
subtracted from total Rb+ uptake (in the absence of ouabain) Values are averages +/SEM.
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Results
Effects of PGs and cAMP on ATP1B1 Gene Transcription
In order to determine whether expression of the Na,K-ATPase β1 subunit gene
(ATP1B1) is regulated by PGs in primary RPT cells, transient transfection studies were
conducted with pHß1-1141 Luc (22). Fig. 1A shows stimulatory effects of an 18 hr
incubation with either 1.4 µM PGE1 (5.1 +/- 0.5 fold) or 1 mM 8Br-cAMP (4.7 +/- 0.8
fold) on luciferase gene expression. Fig. 1B compares the effects of 0.14 µM PGE1,
PGE2 and PGF2α following an 18 hr incubation. The results indicate that both PGE1 and
PGE2 were stimulatory to an equivalent extent (5.1 +/- 0.5 fold, and 6.9 +/- 1.7 fold,
respectively). The stimulatory effects of PGE1 and PGE2 were significantly higher than
the effect of PGF2α (3.0 +/- 0.2 fold). These results are consistent with the involvement
of EP receptors (which have a high affinity for PGE1 and PGE2), rather than FP receptors.
The concentration dependence of the PGE2 effect was then examined, because PGE2 is
the major PG synthesized in the kidney (9). Fig 1C shows a maximal effect of PGE2 was
obtained at 0.28 µM.
Expression of EP Receptors in Primary RPT Cell Cultures
PGE1 and PGE2 stimulate ATP1B1 transcription through a number of signaling
pathways, which are initiated by the interaction of PGE1 and PGE2 with specific PGE
receptors. In the kidney, PGE1 and PGE2 interact with 4 different classes of G Protein
Coupled EP Receptors (40) including EP2 and EP4, which are coupled to adenylate
cyclase (AC) via Gs, EP3, which is coupled to AC via Gi, and EP1, which is coupled to
Phospholipase C (PLC) via Gq.

Although all 4 EP receptors are present in the kidney

17

(11), the EP receptors present in the RPT have not clearly been defined. The receptors,
which are responsible for mediating PGE1 and PGE2 action in the RPT (and thus the
possible signaling pathways involved) had not yet been defined. Thus, RealTime PCR
was employed to quantitate the level of expression of the mRNAs for the 4 EP receptors
in primary RPT cells and purified RPTs.

The relative level of expression of each

mRNA was compared to that in the medulla, a previously studied tissue (13).

Fig. 2A shows that a significant level of each of the 4 EP receptor mRNAs was present in
primary RPTs as well as purified proximal tubules. While the level of EP2 and EP3
mRNA was equivalent to that of purified proximal tubules (1.0 +/0.04 and 1.04 +/- 0.22
fold, respectively), the level of EP1 and EP4 mRNA was significantly lower (0.71+/0.03 and 0.30 +/- 0.03 fold of the level in purified proximal tubules, respectively). In both
primary RPTs and purified RPTs, the level of all EP receptors was significantly lower
than in the medulla, including in particular EP3 (Fig. 2B).

Involvement of Gs Coupled EP Receptors
In order to determine whether Gs coupled EP2 and EP4 receptors mediate the PGE
response, transient transfection studies were conducted using EP2 and EP4 specific
agonists and antagonists over a 4 hr incubation. The EP2 specific agonist butaprost, as
well as the EP2 and EP4 specific agonists PGE1-OH and 16,16 dimethyl PGE2 were
used. As shown in Fig. 3A, both butaprost (0.1 µM) and PGE1-OH (0.5 µM) were
stimulatory. Similarly, as shown in Fig. 3B, 16,16 dimethyl PGE2 (0.25 µM)(16, 17),
caused a 6.1 +/- 0.6 fold stimulation (equivalent to that of PGE1 and PGE2). While the
results with butaprost clearly indicate that EP2 receptors can mediate a stimulatory effect
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on ATP1B1 transcription, the results with PGE2-OH and 16,16-dimethyl PGE2 could also
be explained by EP4 receptor mediated events.

In order to determine whether EP4 receptors are indeed involved, 2 highly specific EP4
antagonists, L161,982 and MF191, were employed at concentrations known to
specifically inhibit PGE action via EP4 receptors (44) (42). Fig. 3C shows that 0.25 µM
L161,982 and 0.01 µM MF191 both inhibit the PGE1 stimulation by 81 +/- 3 % and 83
+/- 7%, respectively.

In order to further evaluate whether Gs coupled EP2 and EP4 receptors are involved, we
examined the effects of PKI (a myristolyated PKA inhibitor) and the AC inhibitor
SQ22536 on the PGE1 stimulation. As shown in Fig. 3D, 10 µM PKI and 0.3 mM
SQ22536 inhibited the PGE1 stimulation by 39 +/- 3%, and 48 +/- 0.5%, respectively.
The stimulatory effect of 8BrcAMP (shown in Fig. 1 above) is also consistent with these
results.

Involvement of Gq Coupled EP1 Receptors
In order to determine whether Gq coupled EP1 receptors are also involved, the effects of
several EP1 specific agonists and antagonists were examined. Fig. 4A shows that the
EP1 agonist 17-phenyl trinor PGE2 was significantly stimulatory at concentrations
ranging from 5 µM (3.1 +/- 0.3 fold) to 20 µM (4.4 +/- 0.3 fold). In contrast, two EP1
receptor antagonists, SC51089 (1 µM) and AH6809 (1 µM) (16), were significantly
inhibitory to the PGE1 stimulation (Fig. 4B). Thus, these results suggest that both the
activation of PLC and AC are involved in mediating the PGE stimulation.
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Role of Ca2+ and PKC
Consequences of the activation of PLC include an increase in intracellular Ca 2+ and
the activation of PKC. Consistent with the involvement of PKC, is the observation
(shown in Fig. 5A) that phorbol 12-myristate-13 acetate (TPA) was stimulatory between
10-9 and 10-7 M. A maximal effect of this PKC activator was obtained at 10 -9 M (3.2 +/0.5 fold control).

In order to determine whether the PGE1 stimulation depends upon the activation of PKC,
the PKC inhibitor GÖ 6976 was employed. As shown in Fig. 5B, 40 nM GÖ 6976 reduced
the PGE1 stimulation by 71 +/- 4% (such that a 1.6 +/- 0.2 fold stimulation was obtained
with + GÖ 6976 and PGE1, as compared with 4.8 +/- 0.5 fold with PGE1 alone). Fig. 5B
shows that 40 nM GÖ 6976 similarly reduced the stimulatory effect of 10 -9 M TPA. A
1.8 +/- 0.2 fold stimulation was obtained with TPA and GÖ 6976, as compared with a 2.8
+/- 0.3 fold stimulation with TPA and a 1.5 +/- 0.1 fold stimulation with GÖ 6976. GÖ
6976 (at 40 nM) inhibits PKC α, PKC ß1 and PKC µ. Ro-32-0432, which inhibits the
PKC α and PKC ß1 at 25 nM, similarly reduced the TPA stimulation (Fig. 5C). Thus
these results support the hypothesis that the PGE1 stimulation of ATP1B1 gene
transcription is dependent upon the activation of PKC α and/or PKC ß1, a consequence
of signaling through EP1 receptors. However because the inhibition produced by the
PKC inhibitors was only partial, the results are also consistent with the involvement of
other classes of EP receptors.
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EP1 receptor activation has been observed to cause an increase in intracellular Ca2+,
which contributes to the activation of PKC (17). In order to determine whether such an
increase in intracellular Ca2+ is sufficient to affect ATP1B1 gene transcription, the effects
of a) ionomycin, a Ca2+ ionophore which increases cytoplasmic Ca 2+, b) BAPTA-AM, a
Ca 2+ chelator which reduces cytoplasmic Ca 2+, and c) TMB-8 , an agent which inhibits
Ca2+ efflux from intracellular stores (9), were examined. Fig. 6A shows that 1 µM
ionomycin causes a 2.3 +/- 0.5 fold stimulation. The stimulatory effect of ionomycin was
reduced in the presence of 2.5 x 10 -5 M BAPTA-AM (to 1.4 +/- 0.2 fold of Control). In
contrast, as shown in Fig. 6B, 10–4 M TMB-8 was stimulatory after a 19 hr. incubation.
Thus, the effects of agents that perturb intracellular Ca 2+ on ATP1B1 transcription
depend upon their specific underlying mechanisms of action.

Actions of Endogenously Produced Renal Effector Molecules.
The RPT produces PGs and other AA metabolites in response to changes in dietary
Na+ (33, 34). Thus, the effect of AA on transcription was examined as a function of AA
concentration. An 18 hr incubation period was employed, so as to allow for substantial
metabolism of AA. Fig. 7A shows that AA caused a significant stimulation between 10–
10

to 10–7 M, with a maximal effect at 10-9 M. In order to determine whether the

stimulatory effect of AA depends upon its metabolism by cyclooxygenase (COX), the
COX inhibitor indomethacin was employed. Fig. 7B shows that 10-6 M indomethacin
reduced the stimulatory effect of 10-9 M AA by 83 +/- 2% (such that only a 2.7 +/- 0.2
fold stimulation was obtained in the presence of indomethacin and AA, as compared with
a 12 +/- 2 fold stimulation obtained with AA alone). Thus, the majority of the

21

stimulatory effect obtained by the addition of AA could be attributed to AA metabolites
generated by COX.

Na,K-ATPase in the RPT is regulated by 20-Hydroxyeicosatetraenoic acid (20-HETE),
and 5,6-Epoxyeicosatrienoic acid (5,6 EET) (34). Fig. 8A shows that a 3.4 fold
stimulation was obtained in response to 10–6 M 20-HETE, an AA metabolite generated by
cytochrome P-450 ω-hydroxylase. Fig. 8B shows that a 2.2 fold inhibition was obtained
in response to 10–6 M 5,6 EET, an AA metabolite generated by cytochrome P450
epoxygenase. Thus, at least 3 different pathways of AA metabolism affect ATP1B1 gene
transcription in the RPT.

The kidney produces catecholamines in response to changes in dietary Na+, including
norepinephrine and dopamine (3) [27]. In order to determine whether norepinephrine and
dopamine affect ATP1B1 transcription, transient transfection studies were conducted
using both 3 and 8 day old cultures. Figure 9A shows that 10 -6 M norepinephrine was
stimulatory in both 3 and 8 day old cultures (causing a 2.2 +/- 0.3, and a 2.1 +/- 0.4 fold
stimulation, respectively). This observation is consistent with the observed stimulatory
effect of norepinephrine on Na,K-ATPase in the RPT. Figure 9A also shows a
stimulatory effect of 10 µM dopamine (1.8 +/- 0.1 fold in both day 3 and 8 in culture).
This latter observation contrasts with the acute inhibitory effect of dopamine on renal
proximal tubule Na,K-ATPase, which results in natriuresis.

Chronic and Acute Effects of PGs on the Na,K-ATPase
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In order to determine whether PGs affect the level of Na,K-ATPase, primary RPT
cells were incubated either in the presence or absence of 1.4 µM PGE1 for 4 days.
Indomethacin was present so as to prevent endogenous PG production. Fig. 10 A and B
show that the level of the α subunit increased by 4.2 +/- 0.6 fold, while the level of
glycosylated and unglycosylated ß subunit increased by 3.3 +/- 0.5 and 4.6 +/- 1.0 fold,
respectively. Fig. 10 C shows that in parallel cultures, the level of α and β subunit
mRNA had increased by 2.2 +/- 0.34 fold and 5.1 +/- 0.4 fold, respectively.

In order to determine whether the PGE-mediated increase in the level of Na,K-ATPase
is associated with an increase in Na,K-ATPase activity, Rb+ uptake studies were
conducted. Primary RPT cell cultures were first incubated for 4 days either in medium
containing 250 ng/ml PGE1., or with no further supplement (Control), followed by Rb+
uptake studies. As shown in Fig. 10D, the initial rate of Rb+ uptake increased by 1.8 +/.2 fold in the presence of PGE1. Fig. 10D also shows that this observed increase in the
Rb+ uptake rate could be explained by an increase in the ouabain-sensitive component of
Rb+ uptake (2.0 +/- 0.3 fold relative to the Control).

Na,K-ATPase activity was also determined in membrane vesicle preparations. In these
studies cultures were treated 4 days with 125 ng/ml PGE1 and 0.125 mM
isobutylmethylxanthine (IBMX), a cAMP phosphodiesterase inhibitor, to further increase
intracellular cAMP levels. Fig. 10E shows that the Na,K-ATPase activity in membrane
preparations derived from cultures treated with PGE1 and IBMX (30.7 +/- 0.5 µmoles/mg
protein/hr) was significantly higher than in membrane preparations obtained from control
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cultures maintained in either presence or the absence of IBMX (1.7 +/- 0.03, and 2.4 +/0.04 fold increase, respectively). Thus, the observed increase in the rate of Rb+ uptake in
PGE1 treated cultures could indeed be explained by an increase in Na,K-ATPase activity.

Acute incubations with effector molecules has been observed to change the level of
basolateral Na,K-ATPase without affecting the overall cellular level of Na,K-ATPase
(23). To study such acute affects, primary RPT cells were cultured on transwell
membranes. Following a 30 min incubation with either a) PGE1, b) butaprost or c) 17phenyltrinor PGE2, basolateral proteins were biotinylated, and purified using Streptavidin
Sepharose. Fig. 11 shows the results of a Western analysis of the biotinylated proteins.
The level of the α subunit increased by 5.4 fold in cultures incubated with 1.4 µM PGE1
, 3.9 fold in cultures incubated with the EP2 agonist butaprost, and 2.6 fold in cultures
incubated with the EP1 agonist 17-phenyltrinor PGE2.

In order to determine whether the acute affects of PGE1 on basolateral Na,K-ATPase
results in a change in Na,K-ATPase activity, 86Rb+ uptake studies were conducted. Fig.
11B shows that following a 30 min incubation with 1.4 µM PGE1, ouabain-sensitive Rb+
uptake increased 43 +/- 2%. A similar increase was observed with 0.125 mM IBMX.
However, in the presence of both 1.4 µM PGE1 and 0.125 mM IBMX the rate of ouabainsensitive Rb+ uptake decreased to 24 +/- 16% of the Control level. These results indicate
that PGE1 does indeed cause an acute increase in Na,K-ATPase activity in primary RPTs
in addition to chronic regulation at the transcriptional level. However the observed
decrease in ouabain-sensitive Rb+ uptake in the presence of IBMX as well as PGE1,
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suggests that acute regulation in response to PGE1 is dependent upon the cells’ cAMP
status.
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Discussion

PGE2 is the major metabolite of COX in all sections of the nephron, including the RPT
(9). PGs produced by RPT, as with all the nephron segments, act as autocrine factors, that
regulate transport and metabolism in the same cells that produce these autocoids (13). In
this report the effects of endogenous PGs have been studied in a primary proximal tubule
(RPT) cell culture system that produces PGs in vitro in a manner similar to intact RPTs
which are present in vivo (1) . RPTs in vivo produce PGs, of which > 90% is PGE2,
followed by PGF2α, and 6-keto-PGF1 α (9). Similarly, PGE2 is produced to the largest
extent by the primary RPT cells (5 ng/mg protein/hr), followed by PGF2α (1 ng/hr) and
α

6-keto-PGF1α (0.6 ng/hr) (1). Thus, the primary cultures produce enough PGE2 within 5
hrs to stimulate Na,K-ATPase β subunit gene expression 7 fold, unlike the case with
PGF2α. Moreover PGE2 has been observed to play a significant role in regulating renal
Na+ reabsorption in the kidney (12) (9, 32, 59).

PGE1 has been found to act in a

virtually identical manner to PGE2, interacting with the same set of receptors (17). For
this reason, the effects of PGE1 as well as PGE2 have been studied.

Previously, G Protein Coupled Receptors (GPCRs) have been identified in the kidney,
which are specific for PGs (12). PGE1 and PGE2 in particular interact with a specific
subset of these GPCRs, the EP receptors (12). Four subtypes of EP receptors have been
identified (11). EP1 receptors are primarily in the collecting duct, where they inhibit Na+
and water reabsorption via a Ca2+ coupled mechanism. Despite the relatively low levels
of renal EP2 receptors, EP2 receptor knockout mice have salt-sensitive hypertension. In
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contrast, EP3 receptor knockout mice are relatively unaffected in their renal
concentrating ability. This finding is surprising in light of the proposed involvement of
EP3 receptors in mediating the inhibitory effects of PGs on vasopressin stimulated salt
and water absorption. Gs-coupled EP4 receptors are expressed primarily in the
glomerulus (12). In addition, EP4 receptors have been proposed to be present at lower
levels in individual nephron segments, including the proximal tubule (12).

Investigations with intact animals indicate that PGs have profound affects on renal
function. However, subsequent to these studies, experiments were conducted with
isolated perfused tubules, because a number of the observed effects on reabsorption in
intact animals may be the indirect consequence of PG affects on renal blood flow (9, 24).
However, only acute affects were studied with isolated perfused tubules, and precise
molecular mechanisms still need to be defined. In vitro cell culture systems are more
amenable to the study of molecular mechanisms than other model systems.

Previously, we studied the chronic effects of PGs on the Na,K-ATPase in MDCK
cells, a model of the distal tubule (65). Our results indicate that PGE1 and PGE2
stimulate the Na,K-ATPase activity in MDCK cells, which could be explained at least in
part by transcriptional control (65) (67). However, it was unclear whether PGs have
similar affects on cells in other nephron segments. Moreover, the physiologic
significance of these studies was unclear, because the MDCK cell line may have changed
during its establishment in culture.
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Thus, in this report we examine the effects of PGs on transcription of the ATP1B1
gene in primary RPT cells, which have just been removed from the animal. Four major
results obtained from these studies include the observations that: 1) Both primary RPT
cell cultures and purified RPTs express EP1, EP2, EP3 and EP4 receptors, albeit to a
lower extent that in the medulla. 2) Gq coupled EP1 receptors as well as Gs coupled EP2
and EP4 receptors mediate the stimulatory effects of PGE1 and PGE2 on ATP1B1
transcription in primary RPTs. These results are based upon the observed inhibitory
effects of the EP1 antagonists SC51089 and AH6809, as well as the EP4 antagonists
L161,982 and MF191. In addition, stimulatory effects of the EP1 agonist 17-phenyl
trinor PGE2, the EP2 agonist butaprost, and the EP2/EP4 agonists PGE1-OH and 16,16
dimethyl PGE2. 3) Other renal effector molecules known to regulate transport in the RPT
stimulate ATP1B1 transcription, including norepinephrine and dopamine. 4) Chronic
treatments with PGE1 and PGE2 result in an increase in the levels of the mRNAs for the
Na,K-ATPase, as well as in the total level of cellular Na,K-ATPase. Acute treatments
result in an increase the level of Na,K-ATPase in the basolateral membrane without an
increase in the overall level of cellular Na,K-ATPase. Both chronic and acute treatment
result in an increase in Na,K-ATPase activity.

The evidence that PGE1 and PGE2 affect primary RPTs via mechanisms similar to
those reported previously in MDCK cells includes our results with the EP1 antagonists
SC51089 and AH6809 (17, 37, 40) and the EP2/EP4 agonist 16,16 dimethyl PGE2(16). In
addition, the involvement of Gs coupled EP2/EP4 receptors was indicated by the ability
of PKAI to inhibit the PGE1 stimulation, as previously described in MDCK (65). Unlike
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EP2 and EP4 receptors, Gq-coupled EP1 receptors are coupled to PLC. A consequence
of the activation of PLC (16) is the generation of diacylglycerol and inositol 1,4,5
trisphosphate, an elevation in intracellular Ca2+, and the activation of PKC. The
stimulatory effects of ionomycin and TMB-8 substantiated the involvement of
intracellular Ca2+. TMB-8 causes a decrease in cytoplasmic Ca 2+. However, at the same
time TMB-8 (like ionomycin) increases the level of Ca2+ in intracellular stores, which
could explain its stimulatory effects. The involvement of PKC was supported by the
inhibitory effects of GÖ 6976 (27, 51) and Ro-32-0432 (8, 71), also as previously
described in MDCK cells (65), a distal tubule model. Thus, PGE1 and PGE2 apparently
regulate ATP1B1 transcription by similar cAMP, as well as Ca2+ mediated mechanisms in
primary RPT cells as well as MDCK cells.

A number of lines of evidence indicate that similar PGE-mediated effects on
transcription of Na,K-ATPase also occur in the renal proximal tubule in vivo. PGE2
infusion into the rat renal interstitium has been reported to enhance Na+ reabsorption by
superficial proximal convoluted tubules (PCTs) (39). PGE2 is produced in the kidney in
response to low doses of Ang II (49), and thus has been proposed to elicit effects on Na+
reabsorption which are similar to those elicited by low doses of Ang II. Included
amongst the mechanisms by which Ang II increases Na+ reabsorption in the PCT is
through its stimulatory effects on Na,K-ATPase (3). Such stimulatory effects of Ang II
on Na,K-ATPase in the RPT contribute to the Na+ retention that occurs in rats with
experimental heart failure (68). In contrast, the distal tubule exhibits decreased Na,KATPase activity in this condition (68). Thus, the PGE-mediated effects on transcription
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of Na,K-ATPase in the distal tubule are elicited under a distinct set of physiologic
conditions in vivo.

In addition to its role as a mediator in Ang II action, PGE2 is also involved in
reversing the inhibitory effects of PTH on solute reabsorption in the rabbit Proximal
Straight Tubule (PST) (19). Included amongst the effects of PTH on the RPT is the
inhibition of the Na,K-ATPase (38) as well as the Na+/Pi cotransport system (7) and the
Na+/H+ antiport system (47). Although effector molecules like PTH also regulate Na,KATPase in the distal nephron, differences in mechanisms have been reported (55).

Our results indicate that the responses of primary RPTs and MDCK cells to PGE1 and
PGE2 are mediated by signal transduction pathways that are similar, albeit not identical.
The EP4 antagonists L161,982 and MF191 inhibited the stimulatory effect of PGE1 in
primary RPT cells, unlike the case with MDCK cells (unpublished). Similarly, Sauvant
et al (56) obtained evidence for the involvement of EP4 receptors in mediating the
stimulatory effects of PGE2 on basolateral organic anion transport in OK cells, another
RPT model system. The investigations of Lopes et al. (43) provide additional evidence
for a role of PGs in transport regulation in the RPT. The studies of these investigators
indicate that the acute inhibitory effect of Ang-(1-7) on Na+-ATPase in the RPT is
mediated by endogenous PGE2 (43), Finally, the investigations of Jensen et al. (35),
indicate that phosphate transport by mouse proximal convoluted tubules is inhibited by
PGE2.
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PGE2 has additional affects on transport in other nephron segments. In the collecting
duct, activation of EP1 by 17-phenyl-trinor PGE2 has been observed to cause inhibition
of Na+ and water reabsorption, while activation of EP3 by MB-28767 had no effect (12)
(11). However EP3 receptors have been localized to the medullary Thick Ascending
Limb (mTAL), where they may exert their effects, although EP2 receptor mRNA has
been detected along the nephron , the cAMP mediated effects of PGE2 on transport in the
CD are not mimicked by the EP2 agonist butaprost, and have instead been attributed to
EP4 receptor activation (12). EP2 receptors have a clearly defined role as vasodialators,
which may explain the hypertension which occurs in EP2 knockout mice (12). In
contrast, EP4 receptors have been proposed to activate salt and water absorption along
the nephron (11).

Because of these other affects of PGE2 in other regions of the nephron, it is important
that our primary RPTs do indeed consist of a population of purified proximal tubule cells.
. Included amongst our previous results which support the contention that the primary
RPTs consist of a highly enriched population of differentiated proximal tubule cells, are
our transport studies. The initial rate of p-AH uptake by basolateral membrane vesicles
obtained from the primary cultures and purified rabbit kidney proximal tubules was
equivalent (72). Similarly, the initial rate of 14C- α-methyl-D-glucopyranoside (α MG)
uptake in the primary RPT cell cultures is comparable to that observed in rabbit kidney
cortical slices (6, 14). The kinetic properties of transport by the Na+/glucose cotransport
system (SGLT1), and the Na+/Pi cotransport system (Npt2) similarly resemble those
defined for SGLT1, and Npt2, respectively, in LLC-PK1 cells cultures (52, 70). The
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observation that the level of SGLT1 remained constant after passaging (64), and the
expansion of clonal isolates of RPTs, following their immortalization with SV40 early
region genes (66), also supports the contention that the primary cultures consist of a
highly purified population of proximal tubule cells.

In addition, our results with apical membrane proteins indicate that the primary RPTs
are highly enriched with proximal tubule cells. The primary RPTs express γ-GT , alkaline
phosphates and leucine aminopeptidase. Over 90% of the primary RPTs express γ-GT,
as do the purified proximal tubule preparations, In addition, all 5 of our immortalized
RPT clones, like the primary RPTs, express these apical membrane proteins (14).

Finally, the hormone responsiveness of the primary cultures is consistent with the
contention that these cultures consist of a highly purified population of RPTs. The
primary cultures possess PTH-sensitive adenylate cyclase activity, while lacking
responsiveness to arginine vasopressin and calcitonin. In contrast, the renal cortex
exhibits a significant response to arginine vasopressin and calcitonin due to a small
proportion of cells derived from the distal tubule and loop of Henle (46).

The Na,K-ATPase consists of an α subunit with catalytic activity, as well as a β
subunit required for the integration of Na,K-ATPase into the plasma membrane (26).
The β subunit has been proposed to be a limiting factor in the formation of intact α/ß
heterodimers (excess α subunits being rapidly degraded) (26). Indeed over-expression
of the β1 subunit has been observed to result in a corresponding increase in the
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expression of endogenous α in a number of cell systems including Xenopus Laevis
oocytes (58), and Moloney Sarcoma Virus - transformed MDCK cells (53). However,
recently, Laughery et al. (41) have reported that over-expression of flag tagged β1 in
MDCK cells does not lead to a significant change in expression of either endogenous α
or β1 Na,K-ATPase subunits. In this report, the observed increase in transcription of the
β1 subunit is associated with an increase in the level of both the α and β subunits in the
primary RPT cell cultures. In addition, α as well as β subunit mRNA levels increase in
primary RPTs in response to PGE. Thus, additional studies are necessary to evaluate
whether an increase in α subunit gene transcription also plays a role in regulating the
level of Na,K-ATPase in the proximal tubule.

Our results indicate that β subunit gene expression increases to a large extent that α
subunit gene expression both in primary RPT cells and in MDCK cells. The results that
we obtained by means of RealTime PCR indicate that in primary RPTs treated with 0.7
µM PGE1, the level of β subunit mRNA increased to a 2 fold higher extent than the level
of α subunit mRNA. We obtained a similar result previously through a Northern analysis
of 8BrcAMP treated primary RPTs (30). A consequence of the increased expression of
the Na,K-ATPase α and β subunit mRNA levels in PGE treated primary RPTs is an
increase in the level of the Na,K-ATPase, as well as in Na,K-ATPase activity. However,
the results of our Western analysis of Na,K-ATPase α and β subunits indicates that the
observed increase in unglycosylated β subunit in PGE1 treated primary RPTs was only
slightly higher (10%) than the increase in α subunit. The increase in the level of
glycosylated β subunit did not differ significantly than the observed increase in the α
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subunit. Similarly, in MDCK cells we previously reported a 7 fold increase in β subunit
mRNA and a 2 fold increase in α subunit mRNA mediated by PGE1 concentrations (65).
Nevertheless, the increase in the α subunit level did not differ significantly from the level
of the β subunit in MDCK cells. However, consistent with β subunit being limiting are
our preliminary results with MDCK cells that indicate a knockdown of the β subunit with
β subunit siRNA results in a reduction in the α subunit level.

PGs are modulators of renal microvascular hemodynamics and renin release as well as
tubular salt and water reabsorption (11). PG biosynthesis by cyclooxygenase (COX)
occurs in all sections of the nephron, including the RPT (9, 11). Thus, the stimulatory
effect of AA on transcription by pHß1-1141 Luc can very likely be attributed to autocrine
effects of endogenously produced AA metabolites, including PGE2. Indeed, the
stimulatory effect of PGE2 was inhibited over 80% by the COX inhibitor indomethacin.
However, our results indicate that AA metabolites, including metabolites generated by
cytochrome P450 (such as 20-HETE) also contribute to the stimulatory effect of AA (60).

In addition, our results indicate that several other intra-renal factors, norepinephrine
and dopamine, regulate ATP1B1 transcription in primary RPT cells. Previously, both
norepinephrine and epinephrine were observed to cause an acute increase in renal Na,KATPase activity in the RPT, characterized by a redistribution of Na,K-ATPase from the
cytosolic to basolateral compartment (3). Norepinephrine and epinephrine are produced
in two distinct locales, in response to distinct stimuli. While epinephrine is produced by
the adrenal gland in response to stress, norepinephrine is produced by renal nerves when
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dietary Na+ is low. When dietary Na+ is reduced for a lengthy time, chronic regulatory
mechanisms also come into play (2).

The consequence is an increase in transcription of

the ATP1B1 gene in response to norepinephrine, as we have observed here.

Unlike norepinephrine, dopamine, is produced in the RPT from L-DOPA by an
aromatic L-amino acid decarboxylase (4). Following the biosynthesis of dopamine in the
RPT (presumably when dietary salt intake increases), dopamine acts via dopamine D1like receptors so as to acutely inhibit the RPT Na,K-ATPase. In contrast, dopamine has a
chronic stimulatory effect on ATP1B1 gene transcription in primary RPTs. This
stimulation may possibly be the consequence of signaling through dopamine D2-like
receptors. Indeed, Narkar et al (48) have reported a dopamine D2-like receptor mediated
stimulation of Na,K-ATPase in rat RPTs treated with the D2 agonist bromocriptine.
Similarly, a stimulatory effect of dopamine on Na,K-ATPase has been observed in lung
alveolar epithelial cells, and has been attributed to a stimulation of ATP1B1 gene
transcription (28).

Similarly, chronic effects of PGs on Na,K-ATPase on primary RPTs differ from
previously reported acute affects in collecting duct cells, both in vitro and in vivo (15).
In primary RPTs a stimulatory effect of PGE1 and PGE2 was observed following an acute
as well as a chronic treatment. These results may accurately reflect long-term as well as
short-term regulation in the RPT in response to increases in the levels of PGs, and
changes in Na+ balance (59). During short-term fluctuations in Na+ balance, the
tubulogomerular feedback mechanism stabilizes renal Na+ secretion (59). Long-term
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changes in Na+ balance are characterized by an altered rate of renin secretion, as well as
changes in the level of Ang II, and COX 2 in the macula densa (59). Increases in
ATP1B1 gene transcription in the RPT cells may be one of the consequences of such
changes in renal cortical COX 2 activity, in addition to other long-term physiologic
changes.
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Figure Legends
Figure 1. Effects of Prostaglandins on Transcription. Primary RPT cells were
transfected with pH ß1-1141 Luc and pSVßgal, as described in Materials and Methods.
A) Effect of PGE1 and 8Br-cAMP. Transfected primary RPT cells were incubated for 18
hr either in DME/F12 supplemented with 5 µg/ml insulin and 5 µg/ml transferrin
(Control), Control Medium with 1.4 µM PGE1 or Control Medium with 1 mM 8BrcAMP. B) Effect of 1.4 µM PGE1, PGE2 and PGF2α. Primary RPT cells were incubated
for 18 hr either in Control medium, or in Control medium further supplemented with 0.14
µM of either PGE1, PGE2 or PGF2α. C) The effect of PGE2 Concentration. Transfected
primary RPT cells were incubated for 18 hrs with PGE2 at concentrations ranging from 0
to 1.4 µM. At the end of the 18 hr incubation the cultures were lysed. After the luciferase
and ß galactosidase activity was determined in each cell lysates, the luciferase activity
was standardized for transfection efficiency. In each condition the fold stimulation of
luciferase activity was compared with the Control. Values are averages +/- SEM of
quadruplicate determinations. * p< 0.05 vs. Control.
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Figure 2. Expression of EP Receptors in RPT Cells. A. The Expression of EP1, EP2, EP3
and EP4 Receptor mRNA in Primary RPT cells was compared to the levels in purified
RPTs as described in Materials and Methods. B. The Expression of EP1, EP2, EP3 and
EP4 Receptor mRNA in primary RPT cells and purified RPTs was compared to the levels
in the medulla. Values are averages +/- SEM of triplicate determinations.

Figure 3. Effects of EP2 and EP4 Receptor Agonists and Antagonists. A) Effects of
butaprost and PGE1-OH. B) Effects of 0.28 µM PGE1, PGE2, and 16-16 dimethyl PGE2
C) Effect of L161, 982 and MF191. D) Effect of PKI and SQ22536. Values are the
averages +/- SEM of quadruplicate determinations. * p<0.05

Figure 4. Effects of EP1 Agonists and Antagonists. A. Effect of 17-phenyltrinor PGE2.
B. Effect of 1 µM AH 6809 and 1 µM SC51089, either in the presence of the absence of
1.4 µM PGE1. * p<0.05 vs Control.

Figure 5. Effects of TPA and PKC Inhibitors. A) Effect of TPA. Primary RPT cell
cultures were incubated for 4 hrs with either 0, 10–9 M, 10-8 M or 10-7 M TPA. B) Effect
of Gö 6976 on the PGE1 Stimulation. Primary RPT cell cultures were incubated for 4 hrs
with either 10-9 M TPA, 1.4 µM PGE1, 1.4 µM PGE1 + Gö 6976, 10–9 M TPA + 40 nM
Gö 6976, or no further supplement (Control). C) Effect of Ro-32-0432 on the PGE1
Stimulation. Primary RPT cells were incubated for 4 hrs with either 1.4 µM PGE1, 10–9
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M TPA, 25 nM Ro-32-0432-1 + 1.4 µM PGE1, 25 nM Ro-32-0432-1 + 10–9 M TPA, 25
nM Ro-32-0432-1, or no further supplement (Control). Differences were statistically
significant when p< 0.05 (*).

Figure 6. Effect of Agents that Modulate Ca2+ Metabolism. Primary RPT cell cultures
were transiently transfected as described in Materials and Methods. Subsequently, effects
of agents that modulate Ca2+ metabolism were examined. A) Effect of Ionomycin and
BAPTA-AM. Primary RPT cell cultures were incubated for 4 hrs either with DME/F12
supplemented with 5 µg/ml insulin and 5 µg/ml transferrin (Control), or in the Control
condition further supplemented with either 1 µM ionomycin, 2.5 x 10–5 M BAPTA-AM
individually, or ionomycin and BAPTA in combination. B) Effects of TMB-8 and
Ionomycin. Primary RPT cell cultures were incubated for 19 hrs either with 10-6 M TMB8 or 1 µM ionomycin. Values were significantly different from the control when p< 0.05
(*).

Figure 7. Effects of Arachidonic Acid and its Metabolites. A) Effect of AA
concentration. Primary RPT cells were transiently transfected with pHß1-1141 Luc and
pSVßgal. Subsequently, the transiently transfected primary RPT cells were incubated for
18 hr with AA at concentrations ranging from 10–10 to 10–7 M. B) Effect of Indomethacin.
Primary RPT cells were preincubated for 30 min. either in the presence or the absence of
10-6 M indomethacin. Subsequently, the cultures were incubated for 18 hr with either 10–
9

M AA, 10-9 M AA with 10 –6 M indomethacin, 10–6 M indomethacin alone, 1.4 µM

PGE2 or with no further supplement (Control). Cultures were lysed and luciferase
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determinations made as described in the legend to Figure 1. Differences were statistically
significant when p<0.05 (*).

Figure 8. Effect of 20-HETE and 5,6-EET. A) Effect of 20-HETE. Primary RPT cells
were incubated for 4 hrs with either 1 µM 20-HETE, 1.4 µM PGE1, 1 mM 8Br-cAMP, or
Control (no further supplement). B) Effect of 5,6 Epoxyeicosatrienoic Acid (5,6-EET).
Primary RPT cells were treated with either 1 µM 5,6 EET, 0.070 µM PGE1 or 0.70 µM
PGE1 for 4 hr. Values were significantly higher than the Control when * p< 0.05 (*), or
lower than the control when ** p < 0.05 vs. AA.

Figure 9. Effect of Norepinephrine and Dopamine on Transcription. Primary RPT cells
were transiently transfected with pHß1-1141 Luc and pSVßgal, after either 3 or 8 days in
culture, as described in Materials and Methods. Subsequently, the primary cultures were
incubated for 4 hrs in Control Medium supplemented with 5 µg/ml insulin, 5 µg/ml
transferrin, 10-6 M indomethacin, and either 1) 10-6 M norepinephrine, 2) 10 µM
dopamine, or 3) no further supplement. Cells were lysed, and luciferase activity
determined as described in the legend to Figure 1. Values are the averages +/- SEM of
quadruplicate determinations. Four independent experiments were conducted.

Figure 10. Chronic and Acute Effects of PGE1 on the Na,K-ATPase A) Chronic Effect
of PGE1 on the level of the Na,K-ATPase in Primary RPT Cell Cultures. Primary RPT
cell cultures were grown to confluence in Medium RK-1 in the presence of 10 -6 M
indomethacin. Subsequently, the cultures were maintained for 4 days in Medium RK-1
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containing 10-6 M indomethacin further supplemented either in the presence or the
absence of 0.7 µM PGE1. The medium was changed daily. At the end of the 4 day
incubation, the level of the α and ß subunit of the Na,K-ATPase was determined by
Western analysis. The level of α and β subunit mRNA was determined by RealTime
PCR. A) Blots of the α and ß subunits as well as beta actin are illustrated. B) The results
of scanning densitometry of α and β blots. Values are averages of duplicate
determinations. C) The results of determinations of α and β subunit mRNA are shown.
Values are averages +/- SEM of triplicate determinations. D) The initial rate of Rb+
uptake was determined both in the presence and in the absence of 1 mM ouabain. Prior to
the uptake study, the primary RPT monolayers were maintained for 4 days in DME/F12
supplemented with 5 µg/ml insulin, 5 µg/ml transferrin, 10-6 M indomethacin, and either
0.7 µM PGE1 or no further supplement (Control). The difference between total Rb+
uptake, and ouabain-insensitive Rb+ uptake (the ouabain-sensitive component) was then
calculated. Values are averages (+/- SEM) of triplicate determinations. E) The activity
of the Na,K-ATPase in cell lysates was determined in primary RPTs monolayers which
were maintained for 4 days in DME/F12 supplemented with 5 µg/ml insulin, 5 µg/ml
transferrin, 10-6 M indomethacin and either 1) 0.35 µM PGE1 and 0.125 mM IBMX, 2)
0.125 mM IBMX alone, or 3) no further supplement (Control). Values are averages (+/SEM) of triplicate determinations.

Figure 11. Acute Effect of PGE1 on the α Subunit. A. Primary RPT cells on transwell
membranes were cultured in Medium RK-1 containing 1 µM indomethacin. Following a
30 min incubation with either 1.4 µM PGE1, 50 µM butaprost or 50 µM 17-phenyltrinor
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PGE2, the basolateral surface of the primary RPT cells was biotinylated. Samples were
precipitated using streptavidin beads, separated by SDS-PAGE, and transferred to
nitrocellulose. The level of the α subunit of the Na,K-ATPase was determined by
Western analysis, as described in Materials and Methods. B. Primary RPT cells in 35
mm dishes were cultured in Medium RK-1 containing 1 µM indomethacin. The
monolayers were incubated for 30 minutes at 23o C with either 1.4 µM PGE1, 0.125 mM
IBMX, 1.4 µM PGE1 + 0.125 mM IBMX or no further supplement (Control), followed
by a 15 min 86Rb+ uptake period, as described in Materials and Methods. Values are
averages of triplicate determinations +/- SEM.
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